Vaccines Market Research Reports & Industry Analysis
Key issues in the global vaccine market today include product safety, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems.
The topic of vaccine safety became prominent during the mid 1970’s with increases in lawsuits filed on behalf of those presumably injured by the diphtheria, pertussis, and tetanus (DPT) vaccine. To respond to public health concerns, Congress passed the National Childhood Vaccine Injury Act (NCVIA) in 1986, which in turn led to the creation of the National Vaccine Program Office (NVPO) within the Department of Health and Human Services (DHHS). NCVIA requires that all healthcare providers who administer vaccines containing diphtheria, tetanus, pertussis, polio, measles, mumps, rubella, hepatitis B, Haemophilus influenzae type b and varicella provide a Vaccine Information Statement (VIS) to the vaccine recipient, their parent or legal guardian prior to each dose. Each VIS contains a brief description of the disease as well as the risks and benefits of the vaccine. The NCVIA also mandated that all healthcare providers report certain adverse events that occur following vaccination. As a result, the Vaccine Adverse Event Reporting System (VAERS) and Vaccine Safety Datalink Project (VSD) were established in 1990. VAERS provides a mechanism for the collection and analysis of adverse events associated with vaccines currently licensed in the U.S.; VSD involved forming partnerships with four large health maintenance organizations (HMOs) to continually monitor vaccine safety. The National Vaccine Injury Compensation Program, which was also created by NCVIA, compensates those individuals who have been injured by vaccines on a no-fault basis. On a global basis, the World Health Organization (WHO) is actively involved in ensuring the quality of vaccines.
Vaccines Industry Research & Market Reports
-
Global Therapeutic Vaccines Market 2019-2023
... malignant diseases that is claiming several lives across countries such as the US, the UK, and Denmark over the past few years. The prevalence of chronic diseases such as Alzheimer’s, asthma, diabetes, and multiple sclerosis ... Read More
-
Technologies Enabling Next Generation Vaccine Development
... subsection overlaps with virus-like particles that has been separately addressed. Virus-Like Particles: Virus-Like Particles are biological nanoparticles having size of around 20-100 nm. Due to the repetitive nature, viral capsid proteins have tendency to self-assemble. ... Read More
-
Global Infectious Vaccines Partnering Terms and Agreements 2014 to 2019: Deal trends, players and financials
... detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors ... Read More
-
Global Vaccine Partnering Terms and Agreements 2014-2019: Deal trends, players and financials
... vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active ... Read More
-
Global Cancer Vaccine Partnering 2014-2019: Deal trends, players and financials
... worlds leading healthcare companies. Trends in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer vaccine partnering contract documents Top cancer vaccine deals by value This report provides details ... Read More
-
Veterinary Vaccines
... Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. ... Read More
-
Cancer Immunotherapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025
... The report predicts the global cancer immunotherapy market to grow with a CAGR of 15.12% over the forecast period from 2019-2025. The study on cancer immunotherapy market covers the analysis of the leading geographies such ... Read More
-
Growth Opportunities in Global Vaccines Market, Forecast to 2024
... have a completely different dynamic. Not only are they largely designed for a healthy cohort but are also exponentially influenced by government actions and policies. While old generation vaccines continue to experience growth, the increasing ... Read More
-
Global Vaccine Contract Manufacturing Market Report 2019-2029
... vaccines segment held 48% of the global vaccine contract manufacturing market. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this ... Read More
-
Global Conjugate Vaccines Market (2017 - 2022)
... for production of low-cost vaccines, and widespread routine vaccination programmes in emerging economies. The market will witness a steady growth, expanding at a compound annual growth rate (CAGR) of 11.7% during 2017-2022, to reach approximately ... Read More
-
Global Veterinary Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)
... expected to be driven by technological innovations in vaccines, increasing awareness regarding animal health, increasing investments by government bodies and associations, increased demand for animal protein, including milk, meat, eggs, and fish, and increased expenditure ... Read More
-
Global Pediatric Vaccine Market 2019-2023
... leading cause of mortality in this population segment. Factors such as rising population as well as environmental and a few genetic factors are contributing to the rapidly growing incidences of infectious diseases. For instance, increased ... Read More
-
Global Vaccine Refrigerators Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
... need to be held at temperatures lower than that of a conventional fridge. The unit provides extremely stable low temperatures to prevent degradation of vaccines and other products, along with options like alarms and backup ... Read More
-
Top 20 Vaccines Manufacturers 2019
... GlaxoSmithKline PLC, and Johnson & Johnson. These companies secured about 76% revenue share in the global vaccines market. How this report will benefit you Read on to discover how you can exploit the future business ... Read More
-
Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
... travelers can get before they visit certain regions across the globe which help protect them from serious diseases. Travel vaccines work by exposing the body to a microorganism or parts of the microorganism of the ... Read More
-
Global Preventive Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)
... is yet to establish itself in the market. In spite of these differences in each segment, the market is continuously experiencing growth, due to the varying degrees of increase of the demand for vaccination for ... Read More
-
Preventive Vaccines Market - Growth, Trends, and Forecast (2019 - 2024)
... is yet to establish itself in the market. In spite of these differences in each segment, the market is continuously experiencing growth, due to the varying degrees of increase of the demand for vaccination for ... Read More
-
Vaccine Adjuvants Market - Growth, Trends, and Forecast (2019 - 2024)
... subunit and synthetic vaccines. Across the world, various governmental organizations are promoting and raising awareness regarding immunization against various diseases, like anthrax, BCG, hepatitis, HPV, influenza, varicella, smallpox, and other conditions. Thus, increasing risk of ... Read More
-
The 2020-2025 World Outlook for Manufacturing Vaccines, Toxoids, Blood Fractions, and Culture Media of Plant and Animal Origin Excluding Diagnostic Products
... culture media of plant and animal origin excluding diagnostic products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2020-2025 World Outlook for Cholera Vaccines
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2020-2025 World Outlook for Influenza A (H1N1) Vaccines
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2020-2025 World Outlook for Pediatric Vaccines
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2020-2025 World Outlook for Vaccines
... (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country ... Read More
-
The 2020-2025 World Outlook for H1N1 Vaccines
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2020-2025 World Outlook for Enteric Disease Diagnostics and Preventative Vaccines
... are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These ... Read More
